Why the study?
There was little knowledge of arginine metabolism and mitochondrial functions across different pulmonary hypertension groups.
Population
PH patients and healthy controls from the Pulmonary Vascular Disease Phenomics Program cohort
Comparison
Different PH groups vs healthy controls
Design
Cohort study
Follow-up
At least 4 years
Authors
Loading...
Mitochondrial and arginine changes may differ by PH group; leaves open targeted interventions pending prospective trials.
Group 1 pulmonary arterial hypertension is characterized by a distinct mitochondrial phenotype in platelets that correlates with clinical outcomes like transplant-free survival.
Farha et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: